May 5, 2021
Caribou Biosciences Announces Appointment of Industry Leader Andrew Guggenhime to its Board of Directors
March 8, 2021
Caribou Biosciences to Participate in Three Upcoming Investor Conferences in March
March 3, 2021
Caribou Biosciences Raises $115M Series C Financing to Advance Next-Generation CRISPR Technologies and Allogeneic Cell Therapy Pipeline
view all press releases
There are no upcoming events at this time.
April 15, 2021
CRISPR treating cancer, Rachel Haurwitz, Co-founder and CEO, Caribou Biosciences
February 23, 2021
Caribou and AbbVie Initiate Development Partnership for CAR T-Cell Products
Caribou Biosciences, Inc.
2929 7th Street, Suite 105
Berkeley, CA 94710